The Wnt antagonist and secreted frizzled-related protein 5: implications on lipid metabolism, inflammation, and type 2 diabetes mellitus
Open Access
- 3 July 2018
- journal article
- review article
- Published by Portland Press Ltd. in Bioscience Reports
- Vol. 38 (4)
Abstract
Various reports have suggested that secreted frizzled-related protein (SFRP) 5 (SFRP5) plays a regulatory role in the processes of cellular proliferation and differentiation, by means of inactivating the Wnt/β-catenin signaling pathway. Recently, SFRP5 has been identified as an anti-inflammatory adipokine, which may be induced during preadipocyte proliferation, differentiation, and maturation. This review aims to identify the recent progress in the research and development of SFRP5 that can play a role in influencing lipid metabolism, inflammation, and type 2 diabetes mellitus (T2DM). Recent evidence has indicated that SFRP5 is capable of stimulating adipocyte differentiation via inhibition of the Wnt/β-catenin signaling pathway. In addition, SFRP5 binding with wingless-type murine mammary tumor virus integration site family, member 5A (Wnt5a), inhibits the activation of c-Jun N-terminal kinase (JNK) downstream of the Wnt signaling pathway. An antagonistic relationship has been found between the reductions in inflammatory cytokine production and serine phosphorylation of insulin receptor substrate-1 (IRS-1) in regard to inhibition of insulin signaling network. By this mechanism, SFRP5 exerts its influence on metabolic function. Based on our review of the current available literature, we support the notion that SFRP5 can be used as a therapeutic target in the treatment of T2DM.Keywords
This publication has 69 references indexed in Scilit:
- MALAT1 promotes osteosarcoma development by regulation of HMGB1 via miR-142–3p and miR-129–5pCell Cycle, 2017
- SFRP1 repression in prostate cancer is triggered by two different epigenetic mechanismsGene, 2016
- Roles of Circulating WNT-Signaling Proteins and WNT-Inhibitors in Human Adiposity, Insulin Resistance, Insulin Secretion, and InflammationHormone and Metabolic Research, 2014
- Axon guidance and injury — lessons from Wnts and Wnt signalingCurrent Opinion in Neurobiology, 2014
- Effect of Sfrp5 on Cytokine Release and Insulin Action in Primary Human Adipocytes and Skeletal Muscle CellsPLOS ONE, 2014
- Plasma SFRP5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistanceDiabetes Research and Clinical Practice, 2013
- Adipogenesis: From Stem Cell to AdipocyteAnnual Review of Biochemistry, 2012
- Sfrp5 coordinates foregut specification and morphogenesis by antagonizing both canonical and noncanonical Wnt11 signalingGenes & Development, 2008
- Regulation of osteoblastogenesis and bone mass by Wnt10bProceedings of the National Academy of Sciences of the United States of America, 2005
- Modulation of the JNK Pathway in Liver Affects Insulin Resistance StatusJournal of Biological Chemistry, 2004